LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: MammaPrint is a 70‑gene expression test that stratifies risk of distant metastasis into UltraLow, Low, High 1, and High 2 categories (photo courtesy of Agendia)

Genomic Subtyping Assays Identify High-Risk Early-Stage Breast Cancers

Two genomic subtyping assays identify aggressive HR+/HER2– tumors driving racial survival disparities. More...
08 Apr 2026
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

Simple Blood Test Enables Multi-Disease Detection from Single Sample

A new cfDNA methylation assay screens for multiple cancers and organ diseases from one blood draw with tissue-of-origin mapping. More...
07 Apr 2026
Image: FINDER is the first molecular point-of-care platform with both FDA 510(k) clearance and CLIA waiver that combines molecular testing with chemistry, coagulation, and immunoassay capabilities on a single multifunctional system (photo courtesy of Baebies)

Rapid Point-of-Care RT-PCR Test Differentiates Influenza A/B and SARS-CoV-2 in Minutes

Baebies has received FDA 510(k) clearance and CLIA waiver for the FINDER Flu A&B/SARS-CoV-2 Test. More...
07 Apr 2026
Image: Monitoring ctDNA is a powerful tool to assess the absence or presence of MRD (Photo courtesy of Natera)

ctDNA MRD Test Identifies Breast Cancer Patients Who May Avoid Surgery

A circulating tumor DNA-based molecular residual disease test identifies older ER+/HER2- breast cancer patients who may forgo surgery. More...
06 Apr 2026
Image: Caris Detect uses AI models to analyze peripheral blood for subtle signals of early-stage cancer (photo credit: Adobe Stock)

WGS MCED Assay Demonstrates Rising Sensitivity and High Specificity

A new WGS-based multi-cancer blood test shows stage-stratified sensitivity with high specificity. More...
06 Apr 2026
image: HPV DNA (ctDNA) measured in blood could help tailor treatment for HPV-related throat cancer (photo credit: Adobe Stock)

Blood-Based ctDNA Test Enhances Risk Assessment in HPV-Related Throat Cancer

New data show circulating tumor HPV DNA, read with pathology, improves risk stratification to tailor therapy in throat cancer. More...
03 Apr 2026
Image: New findings show that transcriptome-enabled profiling can help identify therapeutic opportunities for patients who previously had no actionable results from DNA-only testing (photo courtesy of Shutterstock)

RNA Profiling Uncovers Therapeutic Targets in Solid Tumors

AI-driven RNA profiling reveals therapeutic targets missed by DNA testing in advanced solid tumors. More...
02 Apr 2026
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Urine Analyzer
respons® UDS100


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
ADLM